BR9701313A - Compositions containing an association of aspririn and an anti-xa oligosaccharide and use of an anti-xa olysaccharide optionally in combination with aspirin - Google Patents

Compositions containing an association of aspririn and an anti-xa oligosaccharide and use of an anti-xa olysaccharide optionally in combination with aspirin

Info

Publication number
BR9701313A
BR9701313A BR9701313A BR9701313A BR9701313A BR 9701313 A BR9701313 A BR 9701313A BR 9701313 A BR9701313 A BR 9701313A BR 9701313 A BR9701313 A BR 9701313A BR 9701313 A BR9701313 A BR 9701313A
Authority
BR
Brazil
Prior art keywords
aspririn
olysaccharide
aspirin
oligosaccharide
association
Prior art date
Application number
BR9701313A
Other languages
Portuguese (pt)
Inventor
Roger Cariou
Jacobus Christianus J Stiekema
Original Assignee
Sanofi Sa
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA002199642A priority Critical patent/CA2199642C/en
Priority to EA199700025A priority patent/EA000048B1/en
Priority to AU16319/97A priority patent/AU698456B2/en
Application filed by Sanofi Sa, Akzo Nobel Nv filed Critical Sanofi Sa
Priority to BR9701313A priority patent/BR9701313A/en
Publication of BR9701313A publication Critical patent/BR9701313A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9701313A 1997-03-10 1997-03-17 Compositions containing an association of aspririn and an anti-xa oligosaccharide and use of an anti-xa olysaccharide optionally in combination with aspirin BR9701313A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002199642A CA2199642C (en) 1997-03-10 1997-03-10 Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
EA199700025A EA000048B1 (en) 1997-03-10 1997-03-13 Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of anti-xa oligosaccharide optionally in combination with aspirin
AU16319/97A AU698456B2 (en) 1997-03-10 1997-03-14 Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin
BR9701313A BR9701313A (en) 1997-03-10 1997-03-17 Compositions containing an association of aspririn and an anti-xa oligosaccharide and use of an anti-xa olysaccharide optionally in combination with aspirin

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002199642A CA2199642C (en) 1997-03-10 1997-03-10 Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
AU16319/97A AU698456B2 (en) 1997-03-10 1997-03-14 Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin
BR9701313A BR9701313A (en) 1997-03-10 1997-03-17 Compositions containing an association of aspririn and an anti-xa oligosaccharide and use of an anti-xa olysaccharide optionally in combination with aspirin

Publications (1)

Publication Number Publication Date
BR9701313A true BR9701313A (en) 1998-11-17

Family

ID=27152254

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9701313A BR9701313A (en) 1997-03-10 1997-03-17 Compositions containing an association of aspririn and an anti-xa oligosaccharide and use of an anti-xa olysaccharide optionally in combination with aspirin

Country Status (4)

Country Link
AU (1) AU698456B2 (en)
BR (1) BR9701313A (en)
CA (1) CA2199642C (en)
EA (1) EA000048B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794412B1 (en) * 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
UA80399C2 (en) * 2001-11-13 2007-09-25 Glaxo Group Ltd Use of specific dose of fondaparinux sodium for the treatment of acs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2564468B1 (en) * 1984-05-16 1994-12-23 Choay Sa NOVEL OLIGOSACCHARIDES, THEIR SYNTHESIS PREPARATION AND THEIR BIOLOGICAL APPLICATIONS
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides

Also Published As

Publication number Publication date
CA2199642C (en) 2001-05-08
EA000048B1 (en) 1998-04-30
CA2199642A1 (en) 1998-09-10
EA199700025A1 (en) 1997-12-30
AU698456B2 (en) 1998-10-29
AU1631997A (en) 1998-09-17

Similar Documents

Publication Publication Date Title
PT952829E (en) PHENOFIBRATE PHARMACEUTICAL COMPOSITION WHICH PRESENTS HIGH BIODISPONIBILITY AND ITS PREPARATION
BR9710133A (en) Absorbent article with absorbent foam structure that provides improved menstruation and fit
PT1270565E (en) 4-SUBSTITUTED FURANO-2-SULFONAMIDE AND ITS USE IN THE PREPARATION OF SULFONYLURY DERIVATIVES
BR9800344A (en) Glass composition and use of glass compositions
IL123887A0 (en) Dithiolan derivatives their use and pharmaceutical compositions containing the same
BR9601693A (en) Composition and its uses
BR9608806A (en) Coating composition and use
ID22889A (en) ETHYLENA COOPOLYMER COMPOSITION AND ITS USE
FI955865A0 (en) Water-in-water compositions
BR9302393A (en) FIBER DIETARY COMPOSITES FOR USE IN FOOD
MA26553A1 (en) ALPHA-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
PT946185E (en) PHARMACEUTICAL COMPOSITION COMPOSING A COMPOUND WHICH HAS ANTI-XA ACTIVITY AND AN ANTAGONIST COMPOUND OF THE PLAQUETARY AGGREGATION
PT929516E (en) BENZAMIDINE DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS WITH ANTAGONIST EFFECT OF LTB4
EP0879597A4 (en) Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same
BR8901727A (en) STABLE ORGANOPOLYSILOXAN COMPOSITION IN THE ABSENCE OF UNIT AND HARDENING IN AN ELASTOMER
FI943100A (en) Ansamycin derivatives as anthionogenic and anti-cancer agents
NZ233122A (en) Synergistic pharmaceutical composition comprising ketanserine and an ace inhibitor
BR9707339A (en) Composition of personal care in the form of an aqueous liquid and use of it
BR9508110A (en) Triterpene derivative and medical composition
FI962183A (en) I dispensed and placed the piece for elongated pieces
BR9507451A (en) Pharmaceutical composition use of an amount of (i) a standardized antigen together with an amount of (ii) a polypeptide and product containing an amount of (i) a standardized antigen together with an amount of (ii) a polypeptide
BR9603758A (en) Solvent-free binder composition and its use in one- and two-component coating compositions
BR9612420A (en) Solvent-free coating compositions that can be cured with low emissions
BR9701313A (en) Compositions containing an association of aspririn and an anti-xa oligosaccharide and use of an anti-xa olysaccharide optionally in combination with aspirin
HUP0001381A3 (en) Dolastatin-15 derivatives in combination with taxanes

Legal Events

Date Code Title Description
TE Change of address
PC Transfer

Free format text: AKZO NOBEL N.V. (NL), SANOFI SYNTHELABO (FR)

B25A Requested transfer of rights approved

Owner name: SANOFI-SYNTHELABO (FR)

Free format text: TRANSFERIDO DE: AKZO NOBEL N.V.

B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 31/715, A61K 31/19

Ipc: C07H 17/04 (2009.01), C07C 65/00 (2009.01), A61K 3

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O E 13 DA LEI 9279/96.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.